deltatrials
Terminated INTERVENTIONAL NCT03643822

Adjuncts for Adductor Block: Dexamethasone,Dexmedetomidine, or Combination to Reduce Pain (AADDCToR)

Adjuncts for Adductor Block: Dexamethasone,Dexmedetomidine, or Combination to Reduce Pain. A Randomized Controlled Comparison of the Analgesic Effects Following ACL Repair

Sponsor: University Health Network, Toronto

Conditions ACL Injury
Updated 17 times since 2018 Last updated: Apr 21, 2026 Started: Feb 21, 2020 Primary completion: Apr 16, 2026 Completion: Apr 16, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Since study conception and approval in 2018, we have shown that the analgesic benefit of an adductor canal block is not clinically significant in the setting of ACL reconstruction surgery of the knee.

A observational or N/A phase clinical study on ACL Injury, this trial is terminated or withdrawn. The trial is conducted by University Health Network, Toronto and has accumulated 17 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Study Description(click to expand)

Anterior cruciate ligament repair (ACLR) is a surgical procedure of the knee associated with moderate to severe postoperative pain lasting beyond 24 hours following surgery. Provision of adequate postoperative analgesia is a prerequisite for performing this procedure on outpatient basis. By virtue of their analgesic effects, peripheral nerve blocks (PNBs), such as adductor canal block (ACB), have thus become part of the care standard for this surgical procedure. Though ACB provides effective pain relief, the duration of analgesia associated with this block is limited to eight hours postoperatively. As a result, patients having outpatient ACLR may experience severe pain following discharge, require additional opioid analgesics to control their pain, and even visit the emergency department for acute pain management. Consequently, perioperative care for the young outpatient population undergoing this procedure is an area where improvement is needed. Mixing adjuncts with local anesthetics can prolong the duration of analgesia of PNBs; both dexmedetomidine and dexamethasone have been shown to effectively extend the duration of PNB analgesia by 60% and 80% hours, respectively. The use of dexamethasone is wide spread, and dexmedetomidine is progressively gaining popularity. At Toronto Western Hospital, the use of adjuncts is left to the discretion of the anesthesiologists...

Anterior cruciate ligament repair (ACLR) is a surgical procedure of the knee associated with moderate to severe postoperative pain lasting beyond 24 hours following surgery. Provision of adequate postoperative analgesia is a prerequisite for performing this procedure on outpatient basis. By virtue of their analgesic effects, peripheral nerve blocks (PNBs), such as adductor canal block (ACB), have thus become part of the care standard for this surgical procedure.

Though ACB provides effective pain relief, the duration of analgesia associated with this block is limited to eight hours postoperatively. As a result, patients having outpatient ACLR may experience severe pain following discharge, require additional opioid analgesics to control their pain, and even visit the emergency department for acute pain management. Consequently, perioperative care for the young outpatient population undergoing this procedure is an area where improvement is needed.

Mixing adjuncts with local anesthetics can prolong the duration of analgesia of PNBs; both dexmedetomidine and dexamethasone have been shown to effectively extend the duration of PNB analgesia by 60% and 80% hours, respectively. The use of dexamethasone is wide spread, and dexmedetomidine is progressively gaining popularity.

At Toronto Western Hospital, the use of adjuncts is left to the discretion of the anesthesiologists administering PNB; and dexamethasone is occasionally used to prolong block duration. The alternative approach to prolonging block duration is using ambulatory ACB catheters, but this is an expensive option that is applicable to select patients, and it is not available at the TWH.

Importantly, these adjuncts seem to exert their effect through independent mechanisms; thus there may be an advantage to combining adjuncts together. Further prolongation of the duration of analgesia is desirable, as the prolongation of block duration associated with each of these two adjuncts, alone, falls short of the duration of worst postoperative pain following ACLR. Consequently, the investigators aimed to explore whether the combination of these two adjuncts offers an incremental benefit over either of them alone, by examining their potential additive or synergistic effect.

This randomized controlled trial compares the effect of using perineural dexamethasone, dexmedetomidine, and their combination to Control on the duration of postoperative analgesia in patients having ambulatory ACLR with ACB.

Status Flow

~Sep 2018 – ~Nov 2018 · 2 months · monthly snapshot~Nov 2018 – ~Mar 2019 · 4 months · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~Jul 2019 · 3 months · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Nov 2021 · 7 months · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~May 2023 · 17 months · monthly snapshot~May 2023 – ~Jul 2024 · 14 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Apr 2025 · 7 months · monthly snapshot~Apr 2025 – ~Apr 2026 · 13 months · monthly snapshotApr 28, 2026 – present · 2 months · daily API

Change History

17 versions recorded
  1. Apr 28, 2026 — Present [daily]

    Terminated

    Status: RecruitingTerminated · Phase: PHASE4None

  2. Apr 2025 — Apr 2026 [monthly]

    Recruiting PHASE4

  3. Sep 2024 — Apr 2025 [monthly]

    Recruiting PHASE4

    Status: Active Not RecruitingRecruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE4

  5. May 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

    Status: SuspendedActive Not Recruiting

Show 12 earlier versions
  1. Dec 2021 — May 2023 [monthly]

    Suspended PHASE4

  2. Nov 2021 — Dec 2021 [monthly]

    Suspended PHASE4

    Status: RecruitingSuspended

  3. Apr 2021 — Nov 2021 [monthly]

    Recruiting PHASE4

  4. Jan 2021 — Apr 2021 [monthly]

    Recruiting PHASE4

  5. Apr 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

    Status: Not Yet RecruitingRecruiting

  6. Feb 2020 — Apr 2020 [monthly]

    Not Yet Recruiting PHASE4

  7. Aug 2019 — Feb 2020 [monthly]

    Not Yet Recruiting PHASE4

  8. Jul 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE4

  9. Apr 2019 — Jul 2019 [monthly]

    Not Yet Recruiting PHASE4

  10. Mar 2019 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE4

  11. Nov 2018 — Mar 2019 [monthly]

    Not Yet Recruiting PHASE4

  12. Sep 2018 — Nov 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

The aim of this multi-centered study is to evaluate the effects of two distinct Adductor Canal Block (ACB) adjuncts, dexamethasone and dexmedetomidine, and their combination, on postoperative analgesia in patients undergoing Anterior Cruciate Ligament (ACL) Repair.

Contact Information

Sponsor contact:
  • University Health Network, Toronto
  • Women's College Hospital
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations